Polymerized type I collagen as a treatment for long COVID

Puntos clave

• Symptoms of long COVID improved significantly with polymerized type I collagen treatment, showing efficacy.
• Marked improvement in fatigue and breathlessness was noted after treatment sessions.
• Assessment through immune response markers indicated changes post-intervention with collagen.
• These findings support the potential of polymerized type I collagen in managing long COVID symptoms.